- Market Capitalization, $K 942,675
- Shares Outstanding, K 49,877
- Annual Sales, $ 135,080 K
- Annual Income, $ 8,410 K
- 60-Month Beta 1.36
- Price/Sales 6.98
- Price/Cash Flow 98.37
- Price/Book 3.67
|Period||Period Low||Period High||Performance|
| || |
-0.91 (-4.59%)since 02/03/21
| || |
+3.90 (+25.95%)since 12/03/20
| || |
+4.09 (+27.56%)since 03/03/20
STAMFORD, Conn. (AP) _ Cara Therapeutics Inc. (CARA) on Thursday reported fourth-quarter net income of $78.9 million, after reporting a loss in the same period a year earlier.
SmarTrend identified an Uptrend for Cara Therapeutic (NASDAQ:CARA) on November 11th, 2020 at $15.14. In approximately 4 months, Cara Therapeutic has returned 31.04% as of today's recent price of $19.84....
Cara (CARA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CARA, AMAT, CAT, ROKU, and BABA.
SmarTrend identified an Uptrend for Cara Therapeutic (NASDAQ:CARA) on November 11th, 2020 at $15.14. In approximately 3 months, Cara Therapeutic has returned 31.51% as of today's recent price of $19.91....
Zoetis (ZTS) will report earnings and revenues, and provide other pipeline updates when it releases fourth-quarter 2020 results.
Baudax (BXRX) will provide updates on earnings and revenues when it releases results for fourth-quarter 2020.
Vyleesi sales are likely to be in focus when Palatin (PTN) releases results for the second quarter of fiscal 2021.
SmarTrend identified an Uptrend for Cara Therapeutic (NASDAQ:CARA) on November 11th, 2020 at $15.14. In approximately 3 months, Cara Therapeutic has returned 29.13% as of today's recent price of $19.55....
Cannabis stocks could see new highs this year. Fueling momentum, Jazz Pharmaceuticals (NASDAQ:JAZZ) ...
|Amplify Seymour Cannabis ETF|
|S&P Pharmaceuticals SPDR|
|Bioshares Biotech Clinical Trial|
|US Pharmaceuticals Ishares ETF|
|Defiance Nasdaq Junior Biotechnology ETF|
|3rd Resistance Point||19.76|
|2nd Resistance Point||19.53|
|1st Resistance Point||19.23|
|1st Support Level||18.69|
|2nd Support Level||18.46|
|3rd Support Level||18.16|